Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Esophageal Cancer Market and Epidemiology Insights 2023-2032: Potential Drugs Zanidatamab, Sintilimab, Tislelizumab, and Sotigalimab Expected to Significantly Impact the Market
      Biotech

      Esophageal Cancer Market and Epidemiology Insights 2023-2032: Potential Drugs Zanidatamab, Sintilimab, Tislelizumab, and Sotigalimab Expected to Significantly Impact the Market

      August 17, 2023
      AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults
      Biotech

      AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults

      August 17, 2023
      Interim Report Q2, 2023: Calliditas Therapeutics
      Biotech

      Interim Report Q2, 2023: Calliditas Therapeutics

      August 17, 2023
      IDEAYA Announces First-Patient-In for Company-Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in (Neo)Adjuvant Uveal Melanoma
      Biotech

      IDEAYA Announces First-Patient-In for Company-Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in (Neo)Adjuvant Uveal Melanoma

      August 16, 2023
      BRAF-Mutant Metastatic Melanoma in 7MM, 2023-2032: Unveiling the Emerging Drugs, Therapies, and Unmet Needs
      Biotech

      BRAF-Mutant Metastatic Melanoma in 7MM, 2023-2032: Unveiling the Emerging Drugs, Therapies, and Unmet Needs

      August 16, 2023
      Tetra Pharm Technologies inaugurates new R&D, manufacturing and production facility
      Biotech

      Tetra Pharm Technologies inaugurates new R&D, manufacturing and production facility

      August 16, 2023
      South Africa Biopharmaceuticals Market Outlook Report 2023-2028: Innovating for Wellness – Industry Focuses on Precision Medicine
      Biotech

      South Africa Biopharmaceuticals Market Outlook Report 2023-2028: Innovating for Wellness – Industry Focuses on Precision Medicine

      August 16, 2023
      Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet
      Biotech

      Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet

      August 15, 2023
      Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System
      Biotech

      Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System

      August 15, 2023
      Wheeler Bio Appoints Marc Helouin as Chief Quality and Regulatory Officer
      Biotech

      Wheeler Bio Appoints Marc Helouin as Chief Quality and Regulatory Officer

      August 15, 2023
      « 1 … 109 110 111 112 113 … 139 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026